BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gosselin V, Généreux M, Gagneur A, Petit G. Effectiveness of rotavirus vaccine in preventing severe gastroenteritis in young children according to socioeconomic status. Hum Vaccin Immunother 2016;12:2572-9. [PMID: 27367155 DOI: 10.1080/21645515.2016.1189038] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Schollin Ask L. Global and Swedish review of rotavirus vaccines showed considerable reductions in morbidity and mortality. Acta Paediatr 2021;110:3161-9. [PMID: 34314539 DOI: 10.1111/apa.16046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Olsson-Åkefeldt S, Rotzén-Östlund M, Hammas B, Eriksson M, Bennet R. All-cause gastroenteritis hospitalisations of children decreased after the introduction of rotavirus vaccine in Stockholm. Infect Dis (Lond) 2021;:1-8. [PMID: 34569424 DOI: 10.1080/23744235.2021.1982142] [Reference Citation Analysis]
3 Sun ZW, Fu Y, Lu HL, Yang RX, Goyal H, Jiang Y, Xu HG. Association of Rotavirus Vaccines With Reduction in Rotavirus Gastroenteritis in Children Younger Than 5 Years: A Systematic Review and Meta-analysis of Randomized Clinical Trials and Observational Studies. JAMA Pediatr 2021;175:e210347. [PMID: 33970192 DOI: 10.1001/jamapediatrics.2021.0347] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
4 Isanaka S, Langendorf C, McNeal MM, Meyer N, Plikaytis B, Garba S, Sayinzoga-Makombe N, Soumana I, Guindo O, Makarimi R, Scherrer MF, Adehossi E, Ciglenecki I, Grais RF. Rotavirus vaccine efficacy up to 2 years of age and against diverse circulating rotavirus strains in Niger: Extended follow-up of a randomized controlled trial. PLoS Med 2021;18:e1003655. [PMID: 34214095 DOI: 10.1371/journal.pmed.1003655] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
5 Choi EM. COVID-19 vaccines for low- and middle-income countries. Trans R Soc Trop Med Hyg 2021;115:447-56. [PMID: 33733663 DOI: 10.1093/trstmh/trab045] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 15.0] [Reference Citation Analysis]
6 Gyaase S, Asante KP, Adeniji E, Boahen O, Cairns M, Owusu-Agyei S. Potential effect modification of RTS,S/AS01 malaria vaccine efficacy by household socio-economic status. BMC Public Health 2021;21:240. [PMID: 33509156 DOI: 10.1186/s12889-021-10294-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Lestari FB, Vongpunsawad S, Wanlapakorn N, Poovorawan Y. Rotavirus infection in children in Southeast Asia 2008-2018: disease burden, genotype distribution, seasonality, and vaccination. J Biomed Sci 2020;27:66. [PMID: 32438911 DOI: 10.1186/s12929-020-00649-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 9.0] [Reference Citation Analysis]
8 Sicard M, Bryant K, Muller ML, Quach C. Rotavirus vaccination in the neonatal intensive care units: where are we? A rapid review of recent evidence. Curr Opin Pediatr 2020;32:167-91. [PMID: 31851055 DOI: 10.1097/MOP.0000000000000869] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
9 Schollin Ask L, Liu C, Gauffin K, Hjern A. The Effect of Rotavirus Vaccine on Socioeconomic Differentials of Paediatric Care Due to Gastroenteritis in Swedish Infants. Int J Environ Res Public Health 2019;16:E1095. [PMID: 30934717 DOI: 10.3390/ijerph16071095] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
10 Willame C, Vonk Noordegraaf-Schouten M, Gvozdenović E, Kochems K, Oordt-Speets A, Praet N, van Hoorn R, Rosillon D. Effectiveness of the Oral Human Attenuated Rotavirus Vaccine: A Systematic Review and Meta-analysis-2006-2016. Open Forum Infect Dis 2018;5:ofy292. [PMID: 30539038 DOI: 10.1093/ofid/ofy292] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
11 Nnukwu SE, Utsalo SJ, Oyero OG, Ntemgwa M, Ayukekbong JA. Point-of-care diagnosis and risk factors of infantile, rotavirus-associated diarrhoea in Calabar, Nigeria. Afr J Lab Med 2017;6:631. [PMID: 29435424 DOI: 10.4102/ajlm.v6i1.631] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
12 Hungerford D, Vivancos R, Read JM, Iturriza-Gόmara M, French N, Cunliffe NA. Rotavirus vaccine impact and socioeconomic deprivation: an interrupted time-series analysis of gastrointestinal disease outcomes across primary and secondary care in the UK. BMC Med 2018;16:10. [PMID: 29375036 DOI: 10.1186/s12916-017-0989-z] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 9.4] [Reference Citation Analysis]
13 Nayak MK, De P, Manna B, Dutta S, Bhadra UK, Chawla-Sarkar M. Species A rotaviruses isolated from hospitalized patients over 5 years of age in Kolkata, India, in 2012/13. Arch Virol 2018;163:745-50. [PMID: 29248967 DOI: 10.1007/s00705-017-3670-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]